- Min.Order :0 Metric Ton
- Purity: 99%
- Payment Terms : T/T,
Keywords
Pramipexole Dihydrochloride Pharmaceutical Intermediate Pharmaceutical Chemicals
Quick Details
- Appearance:
- Application:sexual dysfunction
- PackAge:alluminum foil bag
- ProductionCapacity:|Metric Ton|Day
- Storage:
- Transportation:
Superiority:
Pramipexole
1,keywords:Pramipexole,Pramipexole hcl,Pramipexole 2HCL monohydrate (CAS: 191217-81-9 )
Pramipexole (CAS: 104632-26-0 )
Pramipexole Dihydrochloride (CAS: 104632-25-9)
2,info:
| Products: | Pramipexole |
| Cas No. | 191217-81-9 |
| Molecular Formula | C10H21Cl2N3OS |
| Molecular Weight | 302.26 |
| Assay | 99% |
| Package | 100g,1kg, 5kg, 10kg,25KG |
3,Function:
General introduction:Pramipexole dihydrochloride is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson's disease (PD) andrestless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. It is also being investigated for the treatment of clinical depression and fibromyalgia.
Details:
Pramipexole
1,keywords:Pramipexole,Pramipexole hcl,Pramipexole 2HCL monohydrate (CAS: 191217-81-9 )
Pramipexole (CAS: 104632-26-0 )
Pramipexole Dihydrochloride (CAS: 104632-25-9)
2,info:
| Products: | Pramipexole |
| Cas No. | 191217-81-9 |
| Molecular Formula | C10H21Cl2N3OS |
| Molecular Weight | 302.26 |
| Assay | 99% |
| Package | 100g,1kg, 5kg, 10kg,25KG |
3,Function:
General introduction:Pramipexole dihydrochloride is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson's disease (PD) andrestless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Pramipexole has shown robust effects on pilot studies in a placebo-controlled proof of concept study in bipolar disorder. It is also being investigated for the treatment of clinical depression and fibromyalgia.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View